Healthcare / Medical DistributionUpdated 2026-05-10 22:07 UTC

HKG/0874 stock hub

HKG/0874 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/0874is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

40.5B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/0874

In the news

Latest news · HKG/0874

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E12.5

P25 11.7P50 18.9P75 41.4

Trailing P/E12.1

P25 10.7P50 17.9P75 38.5

ROE7.4

P25 -14.7P50 2P75 9.4

ROIC6.7

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/0874 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

236

Groups with data

Currency

CNY

Showing 236 of 236 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	HK
Employees	27,057
Employees Change	-623%
Employees Change Percent	-2.22
Enterprise value	HKD 50.2B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Medical Distribution
Isin	CNE100000387
Last refreshed	2026-05-10
Market cap	HKD 40.5B
Price	HKD 16.74
Price currency	HKD
Rev Per Employee	3,296,123.28x
Sector	Healthcare
Sic	5122
Symbol	hkg/0874
Website	https://www.gybys.com.cn

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	8.27%
EV Earnings	15x
EV/EBIT	13.55x
EV/EBITDA	10.67x
EV/FCF	211.25x
EV/Sales	0.56x
FCF yield	0.59%
Forward P/E	12.46x
P/B ratio	0.85x
P/E ratio	12.09x
P/S ratio	0.45x
PE Ratio10 Y	16.13x
PE Ratio3 Y	12.86x
PE Ratio5 Y	12.75x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	4.1%
EBITDA Margin	4.92%
FCF margin	0.27%
Gross margin	16.11%
Gross Profit	HKD 14.4B
Gross Profit Growth	5.29%
Gross Profit Growth Q	2.56%
Gross Profit Growth3 Y	-2.02%
Gross Profit Growth5 Y	2.19%
Net Income	HKD 3.3B
Net Income Growth	9.15%
Net Income Growth Q	-2.06%
Net Income Growth Years	1%
Net Income Growth3 Y	-10.21%
Net Income Growth5 Y	-2.59%
Pretax Margin	4.67%
Profit Margin	3.75%
Profit Per Employee	HKD 123,743
Profitable Years	29
ROA	2.37
Roa5y	3.43
ROCE	6.57
ROE	7.43
Roe5y	10.89
ROIC	6.65
Roic5y	14.71

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	2.92%
Cagr15y	6.42%
Cagr1y	2.76%
Cagr20y	8.51%
Cagr3y	-9.03%
Cagr5y	-0.2%
Div CAGR10	14.02%
Div CAGR3	17.87%
Div CAGR5	15.37%
EPS Growth	9.16
EPS Growth Q	-2.05
EPS Growth Years	1
EPS Growth3 Y	-10.21
EPS Growth5 Y	-2.59
FCF Growth	-87.31%
FCF Growth3 Y	-52.06%
FCF Growth5 Y	-46.4%
OCF Growth	-46.07%
OCF Growth10 Y	-5.1%
OCF Growth3 Y	-23.58%
OCF Growth5 Y	-23.91%
Revenue Growth	5.29x
Revenue Growth Q	3.58x
Revenue Growth Quarters	1x
Revenue Growth Years	1x
Revenue Growth3 Y	2.96x
Revenue Growth5 Y	3.92x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.92
Assets	HKD 102B
Cash	HKD 14B
Current Assets	HKD 74.9B
Current Liabilities	HKD 46.9B
Debt	HKD 21B
Debt EBITDA	HKD 4.52
Debt Equity	HKD 0.44
Debt FCF	HKD 88.23
Equity	HKD 47.6B
Interest Coverage	7.98
Liabilities	HKD 54.4B
Long Term Assets	HKD 27.1B
Long Term Liabilities	HKD 7.5B
Net Cash	HKD -7B
Net Cash By Market Cap	HKD -17.17
Net Debt EBITDA	HKD 1.59
Net Debt Equity	HKD 0.15
Net Debt FCF	HKD 29.25
Tangible Book Value	HKD 40.3B
Tangible Book Value Per Share	HKD 24.8
WACC	4.45

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.6
Inventory Turnover	5.65
Net Working Capital	HKD 28.6B
Quick ratio	0.97
Working Capital	HKD 27.6B
Working Capital Turnover	HKD 4.07

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.01%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	HKD 0.88
Dividend Years	12
Dividend Yield	5.23%
Ex Div Date	2025-08-29
Last Dividend	HKD 0.44
Payout Ratio	56.15%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	33.4%
1Y total return	2.76%
200-day SMA	18.36
3Y total return	-24.73%
50-day SMA	17.64
50-day SMA vs 200-day SMA	50under200
5Y total return	-0.98%
All Time High	42.5
All Time High Change	-60.61%
All Time High Date	2018-06-13
All Time Low	0.31
All Time Low Change	5,293.04%
All Time Low Date	1998-09-01
ATR	0.27
Beta	0.29
Ch YTD	-5.53
High	16.84
High52	20.4
High52 Date	2025-11-14
High52ch	-17.94%
Low	16.71
Low52	16.47
Low52 Date	2026-04-27
Low52ch	1.64%
Ma50ch	-5.11%
Price vs 200-day SMA	-8.82%
RSI	41.94
RSI Monthly	40.35
RSI Weekly	32.05
Sharpe ratio	0.21x
Sortino ratio	0.61
Total Return	5.25%
Tr YTD	-5.53
Tr15y	154.29%
Tr1m	-2.73%
Tr1w	-0.42%
Tr3m	-13.31%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD 3.7B
Operating Income Growth	-8.71
Operating Income Growth Q	0.76
Operating Income Growth3 Y	-11.33
Operating Income Growth5 Y	-1.33
Operating margin	4.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	876,652,294%
Net Borrowing	4,146,953,850.6
Shares Insiders	0%
Shares Institutions	17.57%
Shares Qo Q	0.04%
Shares Yo Y	-0.01%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD 237.7M
Average Volume	1,147,304.35x
Bv Per Share	27.66
CAPEX	HKD -1.4B
Ch10y	-0.95
Ch15y	78.47
Ch1m	-2.73
Ch1w	-0.42
Ch1y	-2.11
Ch20y	234.8
Ch3m	-13.31
Ch3y	-34.74
Ch5y	-19.71
Ch6m	-13.62
Change	-0.65%
Change From Open	0.18
Close	16.85
Days Gap	-0.83
Depreciation Amortization	736,644,145.7
Dollar Volume	13,860,720
Earnings Date	2026-04-27
EBIT	HKD 3.7B
EBITDA	HKD 4.4B
EPS	HKD 2.06
F Score	4
FCF	HKD 237.7M
FCF EV Yield	0.47x
Financing CF	2,826,893,669
Fiscal Year End	December
Founded	1,997
Goodwill	1,059,367,155.1
Graham Number	24.76552
Graham Upside	47.94
Income Tax	HKD 727M
Investing CF	-7,586,840,009
Is Primary Listing	0
Last Earnings Date	2026-04-27
Last Report Date	2026-03-31
Lynch Fair Value	HKD 6.92
Lynch Upside	-58.65
Ma150	18.37
Ma150ch	-8.85%
Ma20	16.85
Ma20ch	-0.65%
Net CF	-3,119,902,939
Next Earnings Date	2026-08-14
Open	16.71
P FCF Ratio	170.3
P OCF Ratio	24.61
Payment Date	2025-09-26
Position In Range	23.08
Ppne	9,721,375,233
Price Date	2026-05-08
Price EBITDA	HKD 9.23
Ptbv Ratio	1
Relative Volume	0.74x
Revenue	89,183,207,709x
Tax By Revenue	0.82x
Tax Rate	17.44%
Tr20y	412.38%
Tr6m	-13.62%
Volume	828,000
Z Score	2.25

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

HKG/0874 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+5.2%

$0.88 annual per share

Payout ratio

+56.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+15.4%

0 consecutive years of growth

Total shareholder yield

+5.2%

Next ex-dividend date: 2025-08-29

Performance

HKG/0874 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/0874?

Insider, institutional, and short-interest positioning.

Institutional ownership

+17.6%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.0%

Negative means the company is buying back shares.

Technical

HKG/0874 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.9

Neutral momentum band

Price vs 200-day MA

-8.8%

50/200-day relationship not available

Beta (5Y)

0.28

Less volatile than the market

Sharpe ratio

0.21

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/0874

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/0874 stock rating?

hkg/0874 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/0874 analysis?

The full report lives at /stocks/hkg/0874/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/0874?

The latest report frames hkg/0874 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/0874 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.